Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 10, 2018

SELL
$284.6 - $344.99 $260,124 - $315,320
-914 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$315.82 - $393.78 $6,948 - $8,663
-22 Reduced 2.35%
914 $315,000
Q4 2017

Feb 22, 2018

BUY
$358.63 - $469.95 $86,429 - $113,257
241 Added 34.68%
936 $352,000
Q3 2017

Nov 13, 2017

BUY
$431.38 - $504.0 $299,809 - $350,280
695
695 $311,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Kcm Investment Advisors LLC Portfolio

Follow Kcm Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcm Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kcm Investment Advisors LLC with notifications on news.